Synonym
DC_AC50; DC AC50; DC-AC50; DC-AC-50; DC-AC 50; DCAC50; DCAC-50; DCAC 50;
IUPAC/Chemical Name
3-Amino-N-(2-bromo-4,6-difluorophenyl)-6,7-dihydro-5H-cyclopenta[b]thieno[3,2-e]pyridine-2-carboxamide
InChi Key
DFNOJNBNTVQPCA-UHFFFAOYSA-N
InChi Code
InChI=1S/C17H12BrF2N3OS/c18-10-5-8(19)6-11(20)14(10)23-16(24)15-13(21)9-4-7-2-1-3-12(7)22-17(9)25-15/h4-6H,1-3,21H2,(H,23,24)
SMILES Code
O=C(C(S1)=C(N)C2=C1N=C3C(CCC3)=C2)NC4=C(F)C=C(F)C=C4Br
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO (up to 10mg/mL)
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
|
Solvent |
mg/mL |
mM |
| Solubility |
| Soluble in DMSO (up to 10mg/mL) |
0.0 |
100.00 |
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.
Preparing Stock Solutions
The following data is based on the
product
molecular weight
424.26
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Qin X, Wang P, Liang H, Si W. Curcumin suppresses copper accumulation in non-
small cell lung cancer by binding ATOX1. BMC Pharmacol Toxicol. 2024 Aug
21;25(1):54. doi: 10.1186/s40360-024-00784-0. PMID: 39169392; PMCID:
PMC11340132.
2: Inkol JM, Poon AC, Mutsaers AJ. Inhibition of copper chaperones sensitizes
human and canine osteosarcoma cells to carboplatin chemotherapy. Vet Comp Oncol.
2020 Dec;18(4):559-569. doi: 10.1111/vco.12579. Epub 2020 Mar 20. PMID:
32060984.
3: Ding F, Li F, Tang D, Wang B, Liu J, Mao X, Yin J, Xiao H, Wang J, Liu Z.
Restoration of the Immunogenicity of Tumor Cells for Enhanced Cancer Therapy via
Nanoparticle-Mediated Copper Chaperone Inhibition. Angew Chem Int Ed Engl. 2022
Aug 1;61(31):e202203546. doi: 10.1002/anie.202203546. Epub 2022 Jun 21. PMID:
35642869.
4: Wang S, Chen B, Ouyang L, Wang D, Tan J, Qiao Y, Ge S, Ruan J, Zhuang A, Liu
X, Jia R. A Novel Stimuli-Responsive Injectable Antibacterial Hydrogel to
Achieve Synergetic Photothermal/Gene-Targeted Therapy towards Uveal Melanoma.
Adv Sci (Weinh). 2021 Sep;8(18):e2004721. doi: 10.1002/advs.202004721. Epub 2021
Jul 31. PMID: 34331418; PMCID: PMC8456278.
5: Li WY, Kan JL, Wan JJ, Li YA, Song T, Wang B, Guan Q, Zhou LL, Dong YB. A
reactive oxygen species-responsive covalent organic framework for tumor
combination therapy. Chem Commun (Camb). 2023 May 2;59(36):5423-5426. doi:
10.1039/d3cc01136d. PMID: 37066608.
